image: Novel epigenetic immune monitoring tool - Epiontis ID - shows promise in detecting severe immune diseases not currently identified in newborn screenings. This material relates to a paper that appeared in the 1 August, issue of Science Translational Medicine, published by AAAS. The paper, by U. Baron at Epiontis GmbH in Berlin, Germany; and colleagues was titled, "Epigenetic immune cell counting in human blood samples for immunodiagnostics." view more
Credit: Precision for Medicine